{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:59:06Z","timestamp":1759010346663},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1984,10,1]],"date-time":"1984-10-01T00:00:00Z","timestamp":465436800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol."],"published-print":{"date-parts":[[1984,10]]},"DOI":"10.1007\/bf02017375","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T02:03:39Z","timestamp":1123812219000},"page":"456-462","source":"Crossref","is-referenced-by-count":29,"title":["In vitro activity of imipenem \u2014 A review"],"prefix":"10.1007","volume":"3","author":[{"given":"I.","family":"Braveny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02017375_CR1","unstructured":"Shannon, K., Phillips, I.: The in-vitro activity of imipenem (N-formimidoyl thienamycin). Proceedings of the 13th International Congress of Chemotherapy 1983, Vienna, Part 14, p. 1\u201310."},{"key":"BF02017375_CR2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1128\/AAC.22.5.906","volume":"24","author":"J. L. Witte","year":"1982","unstructured":"Witte, J. L., Sapico, F. L., Canawati, H. N.: In vitro susceptibility of methicillin-resistant and methicillinsusceptibleStaphylococcus aureus strains to N-formimidoyl thienamycin. Antimicrobial Agents and Chemotherapy 1982, 24: 906\u2013908.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1128\/AAC.21.6.925","volume":"21","author":"H. L. Muytjens","year":"1982","unstructured":"Muytjens, H. L., van der Ros-van de Repe, J.: Comparative activities of 13\u03b2-lactam antibiotics. Antimicrobial Agents and Chemotherapy 1982, 21: 925\u2013934.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/jac\/7.5.521","volume":"7","author":"R. Wise","year":"1981","unstructured":"Wise, R., Andrews, J. M., Patel, N.: N-formimidoyl thienamycin a novel\u03b2-lactam: an in-vitro comparison with other\u03b2-lactam antibiotics. Journal of Antimicrobial Chemotherapy 1981, 7: 521\u2013529.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017375_CR5","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1128\/AAC.17.6.912","volume":"17","author":"T. Kesado","year":"1980","unstructured":"Kesado, T., Hashizume, T., Asahi, Y.: Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics. Antimicrobial Agents and Chemotherapy 1980, 17: 912\u2013917.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1128\/AAC.19.3.402","volume":"19","author":"L. Verbist","year":"1981","unstructured":"Verbist, L., Verhaegen, J.: In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime. Antimicrobial Agents and Chemotherapy 1981, 19: 402\u2013406.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01641202","volume":"11","author":"G. Tischhauscr","year":"1983","unstructured":"Tischhauscr, G., Kayser, F. H.: The in vitro activity of N-formimidoyl thienamycin compared with other broad-spectrum cephalosporins and with clindamycin and metronidazole. Infection 1983, 11: 219\u2013226.","journal-title":"Infection"},{"key":"BF02017375_CR8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1128\/AAC.18.4.642","volume":"18","author":"F. P. Tally","year":"1980","unstructured":"Tally, F. P., Jacobus, N., Gorbach, S. L.: In vitro activity of N-formimidoyl thienamycin (MK0787). Antimicrobial Agents and Chemotherapy 1980, 18: 642\u2013644.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/AAC.20.1.140","volume":"20","author":"V. A. Tutlane","year":"1981","unstructured":"Tutlane, V. A., v. McCloskey, R., Trent, J. A.: In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone. Antimicrobial Agents and Chemotherapy 1981, 20: 140\u2013143.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/AAC.18.4.557","volume":"18","author":"V. W. Horadam","year":"1980","unstructured":"Horadam, V. W., Smilack, J. D., Montgomery, C. L., Werringloer, J.: In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin. Antimicrobial Agents and Chemotherapy 1980, 18: 557\u2013561.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1128\/AAC.21.1.180","volume":"21","author":"H. C. Neu","year":"1982","unstructured":"Neu, H. C., Labthavikul, P.: Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its\u03b2-lactamase stability. Antimicrobial Agents and Chemotherapy 1982, 21: 180\u2013187.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jac\/10.5.383","volume":"10","author":"J. A. Howard","year":"1982","unstructured":"Howard, J. A., Hince, C. J.: The activity of N-formimidoyl thienamycin (MK0787) againstHaemophilus influenzae andStreptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 1982, 10: 383\u2013390.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017375_CR13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jac\/13.4.353","volume":"13","author":"J. Linares","year":"1984","unstructured":"Linares, J., Perez, J. L., Garau, J., Murgui, L., Martin, R.: Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen\u03b2-lactam antibiotics. Journal of Antimicrobial Chemotherapy 1984, 13: 353\u2013359.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017375_CR14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/AAC.20.4.553","volume":"20","author":"C. E. Cherubin","year":"1981","unstructured":"Cherubin, C. E., Corrado, M. L., Sierra, M. F., Gombert, M. E., Shulman, M.: Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam and N-formimidoyl thienamycin. Antimicrobial Agents and Chemotherapy 1981, 20: 553\u2013556.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/AAC.22.2.302","volume":"22","author":"W. Cullmann","year":"1982","unstructured":"Cullmann, W., Opferkuch, W., Stieglitz, M., Werkmeister, U.: A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed\u03b2-lactam derivatives. Antimicrobial Agents and Chemotherapy 1982, 22: 302\u2013307.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/AAC.19.1.114","volume":"19","author":"W. K. Livingston","year":"1981","unstructured":"Livingston, W. K., Elliot, A. M., Cobbs, C. G.: In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains ofPseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, andEnterococcus spp. Antimicrobial Agent and Chemotherapy 1981, 19: 114\u2013116.","journal-title":"Antimicrobial Agent and Chemotherapy"},{"key":"BF02017375_CR17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/AAC.22.5.926","volume":"22","author":"E. J. Dudek","year":"1982","unstructured":"Dudek, E. J., Stephenson, J. D., Bohnhoff, M., Lerner, S. A.: Susceptibility ofNeisseria meningitidis andNeisseria gononhoeae isolates to N-formimidoyl thienamycin. Antimicrobial Agents and Chemotherapy 1982, 22: 926\u2013929.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1128\/AAC.21.4.678","volume":"21","author":"R. K. Scribner","year":"1982","unstructured":"Scribner, R. K., Wedro, B. C., Weber, A. H., Marks, M. I.: Activities of eight new\u03b2-lactam antibiotics and seven antibiotic combinations againstNeisseria meningitidis. Antimicrobial Agents and Chemotherapy 1982, 21: 678\u2013680.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000238077","volume":"28","author":"M. H. Cynamon","year":"1982","unstructured":"Cynamon, M. H., Granato, P. A.: In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin againstEnterobacteriaceae and staphylococci. Chemotherapy 1982, 28: 204\u2013208.","journal-title":"Chemotherapy"},{"key":"BF02017375_CR20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1128\/AAC.21.4.673","volume":"21","author":"E. D. O'Donnell","year":"1982","unstructured":"O'Donnell, E. D., Freimer, E. H., Gilardi, G. L., Raeder, R.: Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against non-fermentative aerobic gram-negative rods. Antimicrobial Agents and Chemotherapy 1982, 21: 673\u2013675.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jac\/8.5.355","volume":"8","author":"D. M. Livermore","year":"1981","unstructured":"Livermore, D. M., Williams, R. J., Williams, J. D.: In vitro activity of MK0787 (N-formimidoyl thienamycin) againstPseudomonas aeruginosa and other gram-negative organisms and its stability to their beta-lactamases. Journal of Antimicrobial Chemotherapy 1981, 8: 355\u2013362.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017375_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jac\/12.suppl_D.47","volume":"12","author":"F. P. Tally","year":"1983","unstructured":"Tally, F. P., Jacobus, N. V.: Susceptibility of anaerobic bacteria to imipenem. Journal of Antimicrobial Chemotherapy 1983, 12: 47\u201351.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017375_CR23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/AAC.23.4.626","volume":"23","author":"W. E. Owens","year":"1983","unstructured":"Owens, W. E., Finegold, S. M.: Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin. Antimicrobial Agents and Chemotherapy 1983, 23: 626\u2013629.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/AAC.20.4.433","volume":"20","author":"M. Nasu","year":"1984","unstructured":"Nasu, M., Maskell, J. P., Williams, R. J., Williams, J. D.: In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds againstBacteroides spp. Antimicrobial Agents and Chemotherapy 1984, 20: 433\u2013436.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR25","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/AAC.21.6.1016","volume":"21","author":"T. Kesado","year":"1982","unstructured":"Kesado, T., Watanabe, K., Asahi, Y., Isono, M., Ueno, K.: Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics. Antimicrobial Agents and Chemotherapy 1982, 21: 1016\u20131022.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/AAC.21.1.168","volume":"21","author":"D. A. Martin","year":"1982","unstructured":"Martin, D. A., Sanders, C. V., Marier, R. L.: N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria. Antimicrobial Agents and Chemotherapy 1982, 21: 168\u2013169.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR27","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1128\/AAC.20.6.850","volume":"20","author":"V. I. Ahonkhai","year":"1981","unstructured":"Ahonkhai, V. I., Cherubin, C. E., Sierra, M. F., Bokkenheuser, V. D., Shulman, M. A., Mosenthal, A. C.: In vitro susceptibility ofCampylobacter fetus subsp.jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1981, 20: 850\u2013851.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1128\/AAC.21.3.501","volume":"21","author":"A. G. Altes","year":"1982","unstructured":"Altes, A. G., Enciso, M. D., Garcia, P. P., Bueno, A. C.: In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates ofBrucella melitensis compared with those of cefoxitin, rifampin, tetracycline and co-trimoxazole. Antimicrobial Agents and Chemotherapy 1982, 21: 501\u2013503.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/12.suppl_D.37","volume":"12","author":"J. F. Acar","year":"1983","unstructured":"Acar, J. F., Goldstein, F. W., Kitzis, M. D., Gutman, L.: Activity of imipenem on aerobic bacteria. Journal of Antimicrobial Chemotherapy 1983, 12: 37\u201345.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017375_CR30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/AAC.20.6.841","volume":"20","author":"M. H. Cynamon","year":"1981","unstructured":"Cynamon, M. H., Palmer, G. S.: In vitro susceptibility ofNocardia asteroides to N-formimidoyl thienamycin and several cephalosporins. Antimicrobial Agents and Chemotherapy 1981, 20: 841\u2013842.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR31","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1128\/AAC.21.6.1011","volume":"21","author":"M. E. Gombert","year":"1982","unstructured":"Gombert, M. E.: Susceptibility ofNocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim sulfamethoxazole, amikacin and N-formimidoyl thienamycin. Antimicrobial Agents and Chemotherapy 1982, 21: 1011\u20131012.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/9.5.411","volume":"9","author":"V. I. Ahonkhai","year":"1982","unstructured":"Ahonkhai, V. I., Sierra, M. F., Cherubin, C. E., Shulman, M. A.: The comparative activities of N-formimidoyl thienamycin (MK0787), moxalactam, cefotaxime and cefoperazone againstYersinia enterocolitica andListeria monocytogenes. Journal of Antimicrobial Chemotherapy 1982, 9: 411\u2013413.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017375_CR33","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.19.5.789","volume":"19","author":"G. M. Eliopoulos","year":"1981","unstructured":"Eliopoulos, G. M., Moellering, R. C.: Susceptibility of enterococci andListeria monocytogenes to N-formimidoyl thienamycin alone and in combination with an aminoglycoside. Antimicrobial Agents and Chemotherapy 1981, 19: 789\u2013793.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF02017382","volume":"3","author":"H. Haas","year":"1984","unstructured":"Haas, H., Zubi, R., Sacks, T. G.: Susceptibility ofMycobacterium fallax to imipenem and other 20 antimicrobial agents. European Journal of Clinical Microbiology 1984, 3: 489\u2013491.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF02017375_CR35","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.22.6.1079","volume":"22","author":"M. H. Cynamon","year":"1982","unstructured":"Cynamon, M. H., Palmer, G. S.: In vitro susceptibility ofMycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins. Antimicrobial Agents and Chemotherapy 1982, 22: 1079\u20131081.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF02017376","volume":"3","author":"G. Ruckdeschel","year":"1984","unstructured":"Ruckdeschel, G., Ehret, W., Ahl, A.: Susceptibility ofLegionella to imipenem and 27 other beta-lactam antibiotics. European Journal of Clinical Microbiology 1984, 3: 463\u2013467.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF02017375_CR37","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1021\/jm00198a001","volume":"22","author":"W. J. Laenza","year":"1979","unstructured":"Laenza, W. J., Windonger, K. J., Miller, T. W., Christensen, B. G.: N-acentimidoyl- and N-formimidoyl thienamycin derivaties: Antipseudomonal beta-lactam antibiotics. Journal of Medicinal Chemistry 1979, 22: 1435\u20131436.","journal-title":"Journal of Medicinal Chemistry"},{"key":"BF02017375_CR38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/AAC.21.2.341","volume":"21","author":"R. L. Thompson","year":"1982","unstructured":"Thompson, R. L., Fisher, K. A., Wenzel, R. P.: In vitro activity of N-formimidoyl thienamycin and other\u03b2-lactam antibiotics against methicillin-resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1982, 21: 341\u2013343.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR39","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/AAC.23.3.450","volume":"23","author":"N. Markovitz","year":"1983","unstructured":"Markovitz, N., Pohlod, D. J., Saravolatz, L. D., Quinn, E.: In vitro susceptibility patterns of methicillin-resistant and susceptibleStaphylo coccus aureus strains in a population of parenteral drug abusers from 1972\u20131981. Antimicrobial Agents and Chemotherapy 1983, 23: 450\u2013457.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/AAC.25.4.491","volume":"25","author":"B. A. Forbes","year":"1984","unstructured":"Forbes, B. A., McClatchey, K. D., Schaberg, D. R.: Subinhibitory concentrations of imipenem induce increased resistance to methicillin and imipenem in vitro in methicillin-resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1984, 25: 491\u2013493.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/AAC.24.1.61","volume":"24","author":"R. M. Blumenthal","year":"1983","unstructured":"Blumenthal, R. M., Raeder, R., Takemoto, C. D., Earl Freimer, H.: Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococci. Antimicrobial Agents and Chemotherapy 1983, 24: 61\u201369.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR42","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1128\/AAC.22.3.448","volume":"22","author":"R. Auckenthaler","year":"1982","unstructured":"Auckenthaler, R., Wilson, W. R., Wright, A. J., Washington II, J. A., Durack, D. T., Geraci, J. E.: Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci. Antimicrobial Agents and Chemotherapy 1982, 22: 448\u2013452.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1128\/AAC.20.2.204","volume":"20","author":"I. J. Ward","year":"1981","unstructured":"Ward, I. J., Moellering, R. C., Jr.: Susceptibility of pneumococci to 14 beta-lactam agents: comparison of strains resistant, intermediate-resistant and susceptible to penicillin. Antimicrobial Agents and Chemotherapy 1981, 20: 204\u2013207.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jac\/12.4.337","volume":"12","author":"P. Y. Chau","year":"1983","unstructured":"Chau, P. Y., Ling, J., Ng, W. S.: Cefoperazone against carbenicillin-resistant isolates ofPseudomonas aeruginosa; comparison with other newer cephalosporins and N-formimidoyl thienamycin. Journal of Antimicrobial Chemotherapy 1983, 12: 337\u2013345.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017375_CR45","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1128\/AAC.21.4.685","volume":"21","author":"A. J. Matzkowitz","year":"1982","unstructured":"Matzkowitz, A. J., Baltch, A. L., Smith, R. P., Sutphen, N. T., Hammer, M. C., Conroy, J. V.: In vitro comparison of N-formimidoyl thienamycin (MK0787) and azlocillin with three aminoglycosides and ticarcillin againstPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1982, 21: 685\u2013687.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR46","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/AAC.20.4.545","volume":"20","author":"A. S. Prince","year":"1981","unstructured":"Prince, A. S., Neu, H. C.: Activities of new beta-lactam antibiotics against isolates ofPseudomonas aeruginosa from patients with cystic fibrosis. Antimicrobial Agents and Chemotherapy 1981, 20: 545\u2013546.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/AAC.19.1.201","volume":"19","author":"S. Shadomy","year":"1981","unstructured":"Shadomy, S., May, R. S.: N-formimidoyl thienamycin (MK0787): in vitro study. Antimicrobial Agents and Chemotherapy 1981, 19: 201\u2013204.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR48","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1128\/AAC.22.4.711","volume":"22","author":"M. J. Ohm-Smith","year":"1982","unstructured":"Ohm-Smith, M. J., Hadley, W. K., Sweet, R. L.: In vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infections. Antimicrobial Agents and Chemotherapy 1982, 22: 711\u2013714.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR49","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/jac\/7.3.279","volume":"7","author":"M. H. Richmond","year":"1981","unstructured":"Richmond, M. H.: The semi-synthetic thienamycin derivative MK0787 and its properties with respect to a range of\u03b2-lactamases from clinically relevant bacterial species. Journal of Antimicrobial Chemotherapy 1981, 7: 279\u2013285.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017375_CR50","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1128\/AAC.18.5.837","volume":"18","author":"M. Toda","year":"1980","unstructured":"Toda, M., Sato, K., Nakazawa, H., Inoue, M., Mitsuhashi, S.: Effect of N-formimidoyl thienamycin (MK0787) on\u03b2-lactamases and activity against\u03b2-lactamase-producing strains. Antimicrobial Agents and Chemotherapy 1980, 18: 837\u2013838.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR51","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/AAC.18.6.893","volume":"18","author":"M. L. Corrado","year":"1980","unstructured":"Corrado, M. L., Landesman, S. H., Cherubin, C. E.: Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) againstPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1980, 18: 893\u2013896.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR52","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1128\/AAC.17.6.993","volume":"17","author":"H. Kropp","year":"1980","unstructured":"Kropp, H., Sundelof, J. G., Kahan, J. S., Kahan, F. M., Birnbaum, J.: MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities. Antimicrobial Agents and Chemotherapy 1980, 17: 993\u20131000.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR53","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/AAC.19.2.248","volume":"19","author":"J. E. Brown","year":"1981","unstructured":"Brown, J. E., Del Bene, V. E., Collins, C. D.: In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents againstBacteroides fragilis: contribution of beta-lactamase to resistance. Antimicrobial Agents and Chemotherapy 1981, 19: 248\u2013252.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF01640838","volume":"10","author":"I. Braveny","year":"1982","unstructured":"Braveny, I., Machka, K., Elsser, R.: Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin and gentamicin. Infection 1982, 10: 45\u201349.","journal-title":"Infection"},{"key":"BF02017375_CR55","first-page":"725","volume-title":"Current Chemotherapy and Immunotherapy","author":"C. Kallick","year":"1982","unstructured":"Kallick, C., Rice, R., Norsen, J., Rajashekaraiah, K., Marsh, D., McCulley, D., Thadhani, K.: In vitro activity of N-formimidoyl thienamycin againstPseudomonas and staphylococci associated with endocarditis. In: Periti, P., Grassi G. G. (ed.): Current Chemotherapy and Immunotherapy. American Society for Microbiology, Washington, 1982, p. 725\u2013726."},{"key":"BF02017375_CR56","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1128\/AAC.22.6.1064","volume":"22","author":"D. M. Enciso","year":"1982","unstructured":"Enciso, D. M., Lindemann, M. L. M., Gutierrez Altes, A.: In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gramnegative bacilli andStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1982, 22: 1064\u20131066.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR57","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1128\/AAC.22.6.1082","volume":"22","author":"C. Watanakunakorn","year":"1982","unstructured":"Watanakunakorn, C., Tisone, J. C.: Synergism between N-formimidoyl thienamycin and gentamicin or tobramycin against enterococci. Antimicrobial Agents and Chemotherapy 1982, 22: 1082\u20131083.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017375_CR58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jac\/13.2.129","volume":"13","author":"J. Aznar","year":"1984","unstructured":"Aznar, J., Garcia Iglesias, C., Perea, E. J.: Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides. Journal of Antimicrobial Chemotherapy 1984, 13: 129\u2013132.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017375_CR59","first-page":"728","volume-title":"Current Chemotherapy and Immunotherapy","author":"S. H. Zinner","year":"1982","unstructured":"Zinner, S. H., Klastersky, J.: In vitro activity of N-formimidoyl thienamycin (MK0787)alone and combined with other beta-lactam compounds and gentamicin. In: Periti, P., Grassi, G. G. (ed.): Current Chemotherapy and Immunotherapy. American Society for Microbiology, Washington D.C., 1982, p. 728\u2013730."},{"key":"BF02017375_CR60","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/jac\/11.4.311","volume":"11","author":"M. A. Miller","year":"1983","unstructured":"Miller, M. A., Finan, M., Yousuf, M.: In vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins inAeromonas hydrophila andSerratia marcescens. Journal of Antimicrobial Chemotherapy 1983, 11: 311\u2013318.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017375_CR61","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1128\/AAC.26.2.272","volume":"26","author":"M. A. Bertram","year":"1984","unstructured":"Bertram, M. A., Young, L. S.: Imipenem antagonism of the in vitro activity of piperacillin againstPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1984, 26: 272\u2013274.","journal-title":"Antimicrobial Agents and Chemotherapy"}],"container-title":["European Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02017375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02017375\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02017375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:42:01Z","timestamp":1557834121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02017375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,10]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1984,10]]}},"alternative-id":["BF02017375"],"URL":"https:\/\/doi.org\/10.1007\/bf02017375","relation":{},"ISSN":["0722-2211","1435-4373"],"issn-type":[{"value":"0722-2211","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,10]]}}}